Anavex Life Sciences Corp (AVXL)

[jimmy667]

Valid point EBZ. Anavex may continue to enroll every qualified patient they conceivably afford to have in the trials and logistically possible. Until they have parallel data of even greater length of trials in extension with individually optimized dose and treatment protocol for each patient proving they are successfully treating the entire population of the extension trials.
Missling has stated his primary duty is to minimize clinical trial risk. In this fashion they could continue to treat patients on the extensions until there is nearly a dead lock surefire approval evidence collected.
Brilliant! Missling has behaved in a way that advances the science and minimizing risk. I believe his attitude is extremely focused on approval and the get rich quick crowd can be dammed.
Patience.